Treatment of psoriasis with a new UVB-lamp
DOI:
https://doi.org/10.2340/0001555569357359Abstract
Twenty-nine patients with psoriasis took part in a study which compared the therapeutic effect of Philips TL12 with a new narrow-band UVB lamp (Philips TL01). The patients were treated on an out-patient basis and treatment were given 3-5 times weekly for a maximum of 8 weeks. The study was conducted in a randomized left-right double-blind fashion. The total score on the TL01-side decreased rather more than on the TL12-side. Eleven patients preferred the TL01 lamp and one the TL12-side, whereas 17 patients had no preference. One of the drawbacks with the new lamp is that radiation times are almost doubled.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 1989 O Larkö
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
